Streamline Packaging Processes, Increase Patient Safety and Ensure Compliance

Packaging and Labelling 2015 is an industry led event with expert speakers across pharma, biotech, and influential associations such as EFPIA, EGA and GS1.

2015 Speakers Included:

Lilly SA
Carolina Sanchez Cespedes
Head of Packaging
Lilly SA
Hussein Al-Qasim
Serialisation & Tamper Evidence Project Manager
Boehringer Ingelheim
Johannes Schoen
Senior Manager Supply Network Quality Management
Boehringer Ingelheim
Christian Hay
Senior Consultant Healthcare
Chika Umenyiora
QA Manager Artworks
Marcel Zutter
Global Programme ManagerSerialisation

"Broad panel, lots of experiences and very fruitful discussions" - Roche delegate

"Fantastic opportunity to network with industry peers" - GSK delegate


In a highly complex, regulated environment, companies have the challenge of ensuring regulatory compliance and meeting strict implementation deadlines to ensure constant supply of product to market

Industry is seeking the best strategies to increase patient safety and compliance through both innovative packaging design and effective communication of labelling information

Up to 15% of all medicines on the market are estimated to be counterfeit and important focus is being placed on integrating safety features into packaging that are both functional for patients and cost-effective for the company. At the forefront of anti-counterfeit measures, companies are implementing new serialisation to comply with EU FMD and ensure an uninterrupted supply of products to market.

The 2015 Pharmaceutical Packaging and Labelling Summit brings packaging and labelling leaders together into one centre to address that biggest industry issues causing the most discussion across packaging, labelling, artwork and serialisation.

Join us from the 23rd to 25th June 2015 in Basel, Switzerland to:

  • Optimise packaging lines and increase overall process efficiency
  • Increase patient compliance through an improved packaging design
  • Effectively communicate product information through compliant labelling
  • Implement compliant serialisation and discuss future unknowns
  • Maximise patient safety with the integration of cost-effective tamper evident features
  • Streamline artwork capabilities and reduce recalls

2014 saw representatives from companies such as:

  • Meda Pharma
  • Reckitt Benkiser
  • Roche
  • Novartis Pharma AG
  • MHRA
  • Johnson & Johnson
  • Pfizer Wyeth
  • Mylan Inc
  • GS1
  • HCPC
  • Viropharma
  • SwissMedic
  • Blue Sphere Health
  • EAHP
  • Arjowiggins Security
  • Bristol-Myers Squibb GmbH
  • Fresenius Medical Care
  • Eli Lilly
  • CSL Behring
  • Spirig Pharma
  • Vifor Pharma
  • GSK
  • Genericon Pharma
  • Actelion Pharmaceuticals
  • Orion Corporation
  • UCB Pharma S.A.
  • Synthes GmbH
  • Actavis
  • Coloplast Danmark A/S
  • GSK Vaccines
  • K+D AG
  • Abbott Healthcare Products BV
  • Abbott Products Operations
  • NNE Pharmaplan
  • Drossapharm
  • Intertek Expert Services
  • Movianto
  • Rolling Optics
  • Tervakoski Oy
  • SYSTECH International
  • Kessler A.S
  • Be4ward
  • SICPA Product Security S.A
  • Perigord Group
  • Nordvalls
  • Atlantic Zeiser
  • Novo Nordisk A/S
  • Avery Dennison
  • Wessex Technology

Sponsors & Exhibitors
Media Partners

Download the 2015 Agenda

Resource Centre

Visit the Resource Center for complimentary industry related content!

Featured Content

Sponsorship Opportunity

Learn more about sponsor & exhibit opportunities


Become a Pharma IQ Member and receive our weekly newsletter!

Quick Links